(Q44110265)

29 November 2017

title

Duchenne muscular dystrophy fibroblast nodules: a cell-based assay for screening anti-fibrotic agents (English)

1 reference

Duchenne muscular dystrophy

29 November 2017

main subject

1 reference

4

1 reference

29 November 2017

Simona Zanotti

1

1 reference

29 November 2017

Sara Gibertini

series ordinal

2

1 reference

29 November 2017

Paolo Savadori

series ordinal

3

1 reference

29 November 2017

Marina Mora

series ordinal

5

1 reference

29 November 2017

publication date

5 April 2013

1 reference

29 November 2017

published in

Cell and Tissue Research

1 reference

29 November 2017

volume

352

1 reference

29 November 2017

issue

3

1 reference

29 November 2017

page(s)

659-670

1 reference

Cardiac fibroblasts: friend or foe?

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1601-2

Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1601-2

Antifibrotic effects of suramin in injured skeletal muscle after laceration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1601-2

The use of suramin, an antifibrotic agent, to improve muscle recovery after strain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1601-2

Diversity, topographic differentiation, and positional memory in human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1601-2

Tissue repair, contraction, and the myofibroblast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1601-2

Antifibrotic effects of aldosterone receptor blocker (spironolactone) in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1601-2

Formation and function of the myofibroblast during tissue repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1601-2

In vitro anti-fibrotic activities of herbal compounds and herbs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1601-2

Heterogeneous proliferative characteristics of human adult lung fibroblast lines and clonally derived fibroblasts from control and fibrotic tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1601-2

Interacting roles of myofibroblasts, apoptosis and fibrogenic growth factors in the pathogenesis of renal tubulo-interstitial fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1601-2

Decorin gene transfer promotes muscle cell differentiation and muscle regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1601-2

Delayed administration of suramin attenuates the progression of renal fibrosis in obstructive nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1601-2

Neutralizing antibody to TGFbeta modulates stromal fibrosis but not regression of photoablative effect following PRK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1601-2

Improved muscle healing after contusion injury by the inhibitory effect of suramin on myostatin, a negative regulator of muscle growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1601-2

Increased levels of transforming growth factor beta receptor type I and up-regulation of matrix gene program: A model of scleroderma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1601-2

Early treatment with lisinopril and spironolactone preserves cardiac and skeletal muscle in Duchenne muscular dystrophy mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1601-2

Differential proliferation of fibroblasts cultured from normal and fibrotic human lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1601-2

Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1601-2

Mechanisms of pathological scarring: role of myofibroblasts and current developments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1601-2

A synthetic nanofibrillar matrix promotes in vivo-like organization and morphogenesis for cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1601-2

Prevention of muscle fibrosis and myonecrosis in mdx mice by suramin, a TGF-β1 blocker.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1601-2

Spironolactone attenuates experimental uremic cardiomyopathy by antagonizing marinobufagenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1601-2

Quantitative microtiter fibronectin fibrillogenesis assay: use in high throughput screening for identification of inhibitor compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1601-2

Prevention of renal fibrosis by spironolactone in mice with complete unilateral ureteral obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1601-2

Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1601-2

Increased cell surface Fas expression is necessary and sufficient to sensitize lung fibroblasts to Fas ligation-induced apoptosis: implications for fibroblast accumulation in idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1601-2

In vitro models of TGF-beta-induced fibrosis suitable for high-throughput screening of antifibrotic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1601-2

Altered extracellular matrix transcript expression and protein modulation in primary Duchenne muscular dystrophy myotubes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1601-2

Osteopontin is highly expressed in severely dystrophic muscle and seems to play a role in muscle regeneration and fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1601-2

Idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1601-2

10.1007/S00441-013-1601-2

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference